Fatty acid-derived dicarboxylic acid modification mitigates human epidermal growth factor receptor 2-targeted antibody–drug conjugate-induced interstitial lung disease
- DOI
- 10.1016/j.jconrel.2026.115508
- Published
- 2026-11
- Container
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2026.115508,
title = {Fatty acid-derived dicarboxylic acid modification mitigates human epidermal growth factor receptor 2-targeted antibody–drug conjugate-induced interstitial lung disease},
author = {Yuanzheng Li and Yuxuan Yang and Yujie Dai and Teng Yang and Dujuan Wang and Jingyi Zhang and Hongxin An and Jiahui Chen and Ye Lu and Meng Li and Qing Wei and Qiang Wen and Lan Wang and Peng Guo},
year = {2026},
journal = {Journal of Controlled Release},
doi = {10.1016/j.jconrel.2026.115508},
url = {https://doi.org/10.1016/j.jconrel.2026.115508}
}RIS
TY - JOUR TI - Fatty acid-derived dicarboxylic acid modification mitigates human epidermal growth factor receptor 2-targeted antibody–drug conjugate-induced interstitial lung disease AU - Yuanzheng Li AU - Yuxuan Yang AU - Yujie Dai AU - Teng Yang AU - Dujuan Wang AU - Jingyi Zhang AU - Hongxin An AU - Jiahui Chen AU - Ye Lu AU - Meng Li AU - Qing Wei AU - Qiang Wen AU - Lan Wang AU - Peng Guo PY - 2026 JO - Journal of Controlled Release DO - 10.1016/j.jconrel.2026.115508 UR - https://doi.org/10.1016/j.jconrel.2026.115508 ER -
APA
Li, Y., Yang, Y., Dai, Y., Yang, T., Wang, D., Zhang, J., An, H., Chen, J., Lu, Y., Li, M., Wei, Q., Wen, Q., Wang, L., & Guo, P. (2026). Fatty acid-derived dicarboxylic acid modification mitigates human epidermal growth factor receptor 2-targeted antibody–drug conjugate-induced interstitial lung disease. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115508
Source records
- crossref · retrieved 2026-11-07T06:38:52.562Z